Sermorelin is a growth hormone-releasing hormone (GHRH) analog consisting of the first 29 amino acids of GHRH. It has been extensively studied for its ability to stimulate the pituitary gland to produce and release growth hormone naturally.
- Commonly studied for its agonist activity at pituitary GHRH receptors and stimulation of endogenous GH pulse secretion
- Associated with research into age-related decline in somatotropic axis activity and hypothalamic-pituitary signaling
- May support research into IGF-1 biosynthesis, hepatic GH receptor signaling, and downstream anabolic pathways
- Observed in studies examining slow-wave sleep regulation and the relationship between GH pulsatility and sleep architecture
- Frequently referenced in research comparing truncated vs. full-length GHRH analogs for receptor binding affinity
For Research Use Only. This compound is intended exclusively for in-vitro laboratory research by qualified investigators. It is not intended for human or animal consumption, is not a pharmaceutical product, and has not been evaluated by the FDA for safety or efficacy.
Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2

